Exdensur was approved in China as the first and only ultra-long-acting biologic for adult patients suffering from chronic rhinosinusitis with nasal polyps, according to a Wednesday filing. The disease ...

Lunsekimig, a bispecific drug aimed at two popular targets, succeeded in studies in asthma and nasal polyps but missed its mark in an eczema trial.

Overall, the incidence of colorectal cancer has decreased over the decades, largely in part due to the use of screening modalities, such as colonoscopy. Colorectal cancer is the second leading cause ...

From celebrity weight loss stories to concerns about side effects, glucagon-like peptide-1 receptor agonists (GLP-1s) have been all over the news. GLP-1 medicines are FDA-approved to treat type 2 ...

SEATTLE — When we think of vaccines, we may think of them as a tool to fight infections, but scientists are increasingly considering vaccines as a way to fight cancer. In light of March as Colorectal ...

When Kevin Tougher was diagnosed with nasal cavity cancer at 39, he faced the possibility of losing his nose to surgery. A groundbreaking treatment at MSK changed everything — preserving both his ...